期刊文献+

改良ELISA法定量测定血清中段心房利钠肽原的评价及临床应用 被引量:1

Evaluation and Clinical Application of Modified Enzyme-Linked Immunosorbent Assay for Quantitative Determination of Midregional Pro-Atrial Natriuretic Peptide in Serum
下载PDF
导出
摘要 目的建立血清中段心房利钠肽原(MR-proANP)的改良ELISA法定量测定,并探讨其应用价值。方法用定量ELISA法测定患者与健康者的血清MR-proANP,并运用IBM SPSS Statistics 23.0软件对结果进行统计处理。结果该法检出限为1.002pmol/L,平均回收率为98.33%,批内CV为2.64%,批间CV为4.95%。健康者与患者的血清MRproANP值通过对数转换,并用均数±标准差(珚x±s)表示;男性健康者120例、高血压41例、急性心肌梗死(AMI)23例、心功能衰竭37例及获得性肺炎患者41例的血清MR-proANP值分别为1.25±0.48,2.45±0.34,3.10±0.41,2.73±0.51和2.43±0.34pmol/L,差异具有统计学意义(F=166.487,P=0.000);女性健康者120例、高血压40例、AMI 22例、心功能衰竭35例及获得性肺炎患者39例的血清MR-proANP值分别为1.39±0.48,2.73±0.59,3.47±0.69,3.06±0.75和2.70±0.58pmol/L,差异也具有统计学意义(F=122.412,P=0.000)。结论该法灵敏、特异和准确。血清MR-proANP定量测定是诊断高血压、AMI,心功能衰竭和获得性肺炎的较好实验指标。 Objective To establish enzyme-linked immunosorbent assay(ELISA)for the quantitative determination of midregional pro-atrial natriuretic peptide(MR-pro ANP)in serum and to investigate its clinical application.Methods Serum MRpro ANP concentrations of patients and of normal controls were measured by ELISA.IBM SPSS Statistics 23.0 software was employed for statistical analysis in this study.Results The limit of detection(LOD)was 1.002 pmol/L.The average rate of recovery was 98.33%.The intraassay CV was 2.64% and interassay CV was 4.95%,respectively.The serum MRpro ANP value of healthy person and patient were transformed through logarithmic transformation,expressed in Mean±SD.The male value of healthy persons(n=120),hypertension(n=41),AMI(n=23),heart failure(n=37)and acquired pneumonia(n=41)were 1.25±0.48,2.45±0.34,3.10±0.41,2.73±0.51 and 2.43±0.34 pmol/L,respectively.Significant differences were observed in them(F=166.487,P=0.000).The female value were 1.39±0.48,2.73±0.59,3.47±0.69,3.06±0.75 and 2.70±0.58 pmol/L,respectively.Significant differences were observed in them(F=122.4,P=0.000).Conclusion This method is sensitive,specific and accurate.Quantitative detection of MR-pro ANP is now better laboratory test for patients of hypertension,of AMI,of heart failure and of acquired pneumonia.
作者 张华清 汪隆海 张求霞 胡勇 ZHANG Hua-qing;WANG Long-hai;ZHANG Qiu-xia;HU Yong(Xiangya School of Public Health,Cental South University,Changsha 410013,China;a.Department of Clinical Laboratory;2b.Department of Cardiology,Song Qingling Caring Hospital,Anhui Chaohu 238000,China)
出处 《现代检验医学杂志》 CAS 2018年第4期51-54,58,共5页 Journal of Modern Laboratory Medicine
关键词 中段心房利钠肽原 酶联免疫吸附测定 高血压 急性心肌梗死 心功能衰竭 获得性肺炎 midregional pro atrial natriuretic peptide establish enzyme linked immunosorbent assay hypertension acute myocardial infarction heart fallure acquired pneumonia
  • 相关文献

参考文献3

二级参考文献75

  • 1张斗星,沈继龙.弓形虫病实验诊断方法应用进展[J].热带病与寄生虫学,2010,8(2):119-123. 被引量:4
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:788
  • 3许炽熛.寄生虫病实验诊断的进展[J].中华检验医学杂志,2006,29(7):665-668. 被引量:9
  • 4社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3056
  • 5Gaggin HK, Januzzi JL Jr. Biomarkers and diagnostics in heart failure[J]. Biochim Biophys Acta, 2013, 1832: 2442-2450.
  • 6McMurray JJV, Adamopoulos S, Anker SD, et ah ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J, 2012, 33 : 1787-1847.
  • 7Morgenthaler NG, Struck J, Thomas B, et al. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma [ J ]. Clin Chem, 2004, 50: 234-236.
  • 8Goode KM, Nicholls R, Pellicori P, et at. The in vitro stability of novel cardiovascular and sepsis biomarkers at ambient temperature [ J ]. Clin Chem Lab Med, 2014, 52: 911-918.
  • 9Potocki M, Breidthardt T, Reichlin T, et at. Comparison of midregional pro-atrial natriuretie peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure [ J]. J Intern Med,2010, 267:119-129.
  • 10Chenevier-Gobeaux C, Guerin S, Andr6 S, et at. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP[J]. Clin Chem, 2010, 56: 1708-1717.

共引文献2273

同被引文献6

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部